ProPhase Labs has posted a net loss of $947,000 for the third quarter 2010, or $0.06 loss per diluted share, compared to net loss of $1.2m, or $0.09 loss per diluted share, for the comparable period in 2009.
ProPhase’s income from operations was $935,000m, compared to $1.2m for the comparable period in 2009.
The company has posted net sales of $8.31m, for the nine months ended 30 September 2010, compared to $10.71m for the year ago period.
For the nine months ended 30 September 2010, ProPhase Labs has posted a net loss of $2.37m, or $0.17 loss per diluted share, compared to $5.62m, or $0.43 loss per diluted share, for the year ago period.
The company’s income from operations for the nine months ended 30 September 2010 was $2.41m, compared to $5.64m for the year ago period.
ProPhase CEO Ted Karkus said that finally, in the third quarter of 2010, they continued to feel the effects of the retail overstock created by H1N1 related sales in late 2009.
"These trends have all continued into the current quarter which has the net effect of pressuring sales and margins," Karkus said.
"On a positive note, we have worked hard to offset these difficult conditions by reinvigorating the Cold-EEZE brand. We have upgraded our packaging, improved our existing flavors, and introduced a new mint frost flavor which appears to be doing well. We have also continued to improve our key retail relationships."